MetaCap

Praxis Precision Medicines Statistics

NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

300.43-10.47 (-3.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Praxis Precision Medicines by the numbers

Praxis Precision Medicines has a market capitalization of $8.40 billion based on 27.95M shares outstanding. With trailing EPS of $-12.82, Praxis Precision Medicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% above its 50-day average and 4.5% below its 200-day average.

Average daily trading volume is 479.87K shares, or about $144.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PRAX valuation vs. peer median

PRAX compared with the median of 8 peer companies
MetricPRAXPeer medianDifference
Market cap$8.40B$7.86B+7%
Avg. volume479.87K1.18M-59%

Peer median across 8 companies: MDGL, SMMT, PTGX, SYRE, RYTM, ALKS, KNSA, AMRX.

Valuation

Price and trading

Previous close
310.90
Open
310.01
Day range
298.54 – 314.15
52-week range
167.32 – 392.70
52-week change
+76.93%
Beta
—
Volume
806.14K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
8.40B
Forward Pe
-30.62
Eps
-12.82
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
392.70
Week52 Low
167.32
Avg Volume
479.87K
Shares Outstanding
27.95M
Ma50
286.09
Ma200
314.52
Earnings Date
Nov 9, 2026
Pct From52w High
-23.50%
Pct From52w Low
79.55%

Related